SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-284482
Filing Date
2017-09-14
Accepted
2017-09-14 08:04:00
Documents
4
Period of Report
2017-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d451801d8k.htm 8-K 16521
2 EX-1.1 d451801dex11.htm EX-1.1 141207
3 EX-5.1 d451801dex51.htm EX-5.1 10080
4 GRAPHIC g451801g44g98.jpg GRAPHIC 2420
  Complete submission text file 0001193125-17-284482.txt   172417
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 171084618
SIC: 2834 Pharmaceutical Preparations